BIOMAT Database Logo BIOMAT Database Logo

[1st clinical experiences on the use of oral contraceptive Ovosiston in diabetics]. 1970

E Gödel, and B Gödel

UI MeSH Term Description Entries
D007328 Insulin A 51-amino acid pancreatic hormone that plays a major role in the regulation of glucose metabolism, directly by suppressing endogenous glucose production (GLYCOGENOLYSIS; GLUCONEOGENESIS) and indirectly by suppressing GLUCAGON secretion and LIPOLYSIS. Native insulin is a globular protein comprised of a zinc-coordinated hexamer. Each insulin monomer containing two chains, A (21 residues) and B (30 residues), linked by two disulfide bonds. Insulin is used as a drug to control insulin-dependent diabetes mellitus (DIABETES MELLITUS, TYPE 1). Iletin,Insulin A Chain,Insulin B Chain,Insulin, Regular,Novolin,Sodium Insulin,Soluble Insulin,Chain, Insulin B,Insulin, Sodium,Insulin, Soluble,Regular Insulin
D008656 Mestranol The 3-methyl ether of ETHINYL ESTRADIOL. It must be demethylated to be biologically active. It is used as the estrogen component of many combination ORAL CONTRACEPTIVES. 19-Norpregna-1,3,5(10)-trien-20-yn-17-ol, 3-methoxy-, (17alpha)-,Ethinyl Estradiol 3-Methyl Ether,Ethinyl Estradiol 3 Methyl Ether
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D002715 Chlormadinone Acetate An orally active synthetic progestational hormone used often in combinations as an oral contraceptive (CONTRACEPTIVES, ORAL). Pregna-4,6-diene-3,20-dione, 17-(acetyloxy)-6-chloro-,Chlormadinon Acetate,Chlormadinone,Chlormadinone Acetate, (9 beta,10 alpha)-Isomer,Neo-Eunomin,Neo Eunomin,NeoEunomin
D003276 Contraceptives, Oral Compounds, usually hormonal, taken orally in order to block ovulation and prevent the occurrence of pregnancy. The hormones are generally estrogen or progesterone or both. Low-Dose Oral Contraceptive,Oral Contraceptive,Oral Contraceptives,Oral Contraceptives, Low-Dose,Oral Contraceptives, Phasic,Contraceptive, Low-Dose Oral,Contraceptive, Oral,Contraceptives, Low-Dose Oral,Contraceptives, Phasic Oral,Low Dose Oral Contraceptive,Low-Dose Oral Contraceptives,Oral Contraceptive, Low-Dose,Oral Contraceptives, Low Dose,Phasic Oral Contraceptives
D003920 Diabetes Mellitus A heterogeneous group of disorders characterized by HYPERGLYCEMIA and GLUCOSE INTOLERANCE.
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D048909 Diabetes Complications Conditions or pathological processes associated with the disease of diabetes mellitus. Due to the impaired control of BLOOD GLUCOSE level in diabetic patients, pathological processes develop in numerous tissues and organs including the EYE, the KIDNEY, the BLOOD VESSELS, and the NERVE TISSUE. Complications of Diabetes Mellitus,Diabetes-Related Complications,Diabetic Complications,Diabetes Complication,Diabetes Mellitus Complication,Diabetes Mellitus Complications,Diabetes Related Complications,Diabetes-Related Complication,Diabetic Complication

Related Publications

E Gödel, and B Gödel
[Experiences in ambulatory treatment of female diabetics with oral contraceptive agent, Ovosiston].
February 1971, Zeitschrift fur arztliche Fortbildung,
E Gödel, and B Gödel
[1ST EXPERIENCES WITH A NEW ORAL CONTRACEPTIVE].
March 1965, Der Landarzt,
E Gödel, and B Gödel
["1st experiences with Ovosiston in a new dosage--a comparative study of oral contraception with 'old' and 'new' Ovosiston". "Experiences with Ovosiston in contraception. II. " Reply to the viewpoint of D. Kühne].
November 1970, Das Deutsche Gesundheitswesen,
E Gödel, and B Gödel
[Side effects of the oral contraceptive Ovosiston on the blood coagulation system].
December 1970, Zentralblatt fur Gynakologie,
E Gödel, and B Gödel
["1st experiences with Ovosiston in new dosage--a comparative study of oral contraception with 'old' and 'new' Ovosiston". "Experiences with Ovosiston in contraception. II. "Viewpoint concerning works of Chr. Zwahr and H. Geschke].
November 1970, Das Deutsche Gesundheitswesen,
E Gödel, and B Gödel
The effect of the oral contraceptive Ovosiston on the composition of human milk.
August 1972, The Journal of reproductive medicine,
E Gödel, and B Gödel
[Serum proteinase inhibitor capacity during administration of the oral contraceptive Ovosiston].
March 1973, Zentralblatt fur Gynakologie,
E Gödel, and B Gödel
[Liver function and glucose tolerance during treatment with the oral contraceptive ovosiston].
June 1972, Das Deutsche Gesundheitswesen,
E Gödel, and B Gödel
[1st experiences with the clinical use of Eugynon].
September 1968, Minerva ginecologica,
E Gödel, and B Gödel
[Clinical experiences with Ovosiston for inhibition of ovulation].
February 1966, Das Deutsche Gesundheitswesen,
Copied contents to your clipboard!